32
Participants
Start Date
June 20, 2025
Primary Completion Date
December 1, 2026
Study Completion Date
December 1, 2026
Adebrelimab
Adebrelimab 1200mg,ivgtt,D1,Q3W
chemotherapy
"Queue A (lung squamous cell carcinoma patients):~Albumin paclitaxel 260mg/m2, ivgtt,D1 , Q3W Carboplatin AUC=5, D1,Q3W~Queue B (lung adenocarcinoma patients):~Pemetrexed 500 mg/m2, ivgtt,D1,Q3W Carboplatin AUC=5, D1,Q3W"
Zhangzhou Municipal Hospital
OTHER